Established in 2005, is a privately held company specialized in distributing and dispending diverse health care products, medical supplies. Since operating in a sector where human health is the primary essence, MT focused heavily in providing services designed at global standards considering all the dynamics of a sector focused on human health.
MT empowers customers by providing the broadest suite of products and services and deepest range of experience in healthcare. We bring together industry-leading distribution services, proper packaging, services to reduce costs and improve the quality of the sector.
The mission of MT is to maintain its well established position by analyzing the dynamics of the sector, maintain its reputation as a reliable organization providing quality distribution services as a point of access between pharmacies and suppliers, and provide for the needs, demands and expectations of its customers by offering the possible widest range of products with the most favorable commercial terms.
MT has approximately 80 employees, operates in 7 regions and 81 cities.MTHealthcare through its subsidiaries markets various healthcare products over 1500 items that save and sustain the lives of people with diabetic disorder, disc hernia , and other chronic and acute medical conditions. As a local and in some products global, diversified healthcare company, MT applies a unique combination of expertise in medical support devices, pharmaceuticals and biotechnology to create products that advance patient care nationwide.
As of underlining the major success story of MT is being the leader of Blood Glucose Monitoring Systems and consumables / test strips in Turkey ahead of worlds famous companies like ABBOTT , ROCHE , BAYER and JOHNSON&JOHNSON . Monthly sales percentage is around % 33 for strips of the total market.This data is based on IMS figures and calculations.
MT also exclusively distributes 2 patented medical device which are owned by the MT Holding. Such distinctive products and its segments are defined in below paragraphs as Disc Hernia “Back and Neck Ache” and Cranial Implant Systems.
A roundup of the biggest pharma and healthcare stories from Turkey including the investigation of 19 pharma companies by the country’s competition watchdog; Gen Pharma Caucasus Manufacturing’s new plant in…
A roundup of the latest pharma and healthcare news from Turkey including Omya’s new Turkish manufacturing site, Santa Farma’s fourth EU-GMP certification and the collaboration agreement between BioNTech and Turkey’s…
A roundup of the latest pharma and healthcare news from Turkey including Roche Turkey’s digital platform for HCPs and patients, big pharma’s aid to earthquake victims, the Scientific and Technological…
The Middle East and Africa (MEA), the fifth-largest regional pharma market in the world, is rapidly becoming a pharmaceutical powerhouse with both global and local firms taking advantage of the…
After its best financial year to date – posting revenues of USD 27.3 billion in 2021 – Gilead has said yes to localization in Turkey. The California-based company, known for…
Turkey’s pharma market, the 18th largest in the world and valued at USD 7 Billion in 2020, has seen steady growth over the past few years due to favorable healthcare…
With an already well-established manufacturing industry for pharmaceuticals, Turkey has been aiming to move with global trends and invest in biologics production, specifically in biosimilars. The share of biotechnological…
Becoming the clinical trials country leader in the region has been set as a primary goal for Turkey’s pharma industry to achieve global competitiveness. The government’s strategy is to increase…
Few Turkish companies are experiencing such a transformational moment as GEN. In 2021 alone, the Ankara-based organization made its public debut on the Istanbul Stock Exchange and signed an exclusive…
When the Turkish Ministry of Health implemented its strategy to transition from import pharmaceuticals to manufacturing them at home in 2016, the local industry leveraged the situation to invest in…
As an upper-middle-income country with an emerging economy, Turkey could not invest billions in COVID-19 vaccine R&D, but a strong research ecosystem and willing industry allowed it to kickstart multiple…
Overseeing healthcare for a population of over 80 million, Turkey’s Ministry of Health was put under the spotlight during the COVID-19 pandemic. Here, we highlight four of the hot-button items…
See our Cookie Privacy Policy Here
